|
Refractive
General
 |
Verisyse Lens & Visian ICLVision Correction for Myopia These are exciting procedure to offer patients who have had corneas too thin or a refractive error to great for laser vision correction. Overview of the Verisyse Lens Procedure Dr. Milne was one of America 's first 20 surgeons trained in this lens implantation. The Verisyse is for extreme myopia and is approved for –5 to –20 D (available soon for an expanded range to include astigmatism.) Visian ICL: Implantable Collamer® LensSTAAR ® Surgical Company began feasibility studies for treating vision disorders with an implantable contact lens (ICL) in 1993. By 1997, the company received approval to supply its ICL vision correction device to European markets. In 2005, the U.S. Food and Drug Administration (FDA) approved the Visian ICL (Implantable Collamer Lens) for the reduction and treatment of nearsightedness (myopia). Visian ICL is another option for treating myopia. Now, patients who are seeking the latest approved procedures for vision correction or who want to avoid the permanence of laser vision correction have another choice for correction of nearsightedness. What Makes the Visian ICL Different? Although the Visian ICL is often informally defined as an "implantable contact lens," in the United States, the "ICL" in the Visian ICL stands for "implantable Collamer lens." This designation acknowledges the unique material that comprises the lens. Unique Lens Composition The Visian ICL is made from Collamer, a unique, organic lens material, designed especially for this ICL. This proprietary lens material has greater biocompatibility than acrylic and silicone lenses. The Visian ICL is also foldable, requiring a smaller incision during the surgical procedure than other available lenses. Safe, Proven Procedure The safety and effectiveness of Visian ICL implantation procedure has been proven with over 55,000 implants worldwide as well as recent U.S. FDA approval. Unlike corneal refractive surgery, Visian ICL does not permanently alter the structure of the eye. Instead, the phakic IOL is placed in the eye's posterior chamber, where it works with the natural lens to correct vision. This ICL takes refractive surgery beyond the limits of Laser Vision Correction (LASIK, AST, PRK). Small Incision The Visian ICL is foldable which allows physicians to implant the lens using a smaller incision. The small incision procedure is a technique that is familiar to eye surgeons. The Visian ICL requires a 2.8mm to 3.0mm incision as opposed to the 6.0mm incision required by other FDA-approved phakic IOLs. This smaller incision is seen as less invasive, does not require sutures, and is astigmatically neutral. Removable, if Necessary Visian ICL is meant to stay in the eye indefinitely. However, if overcorrection or undercorrection occurs, a complication develops, or a patient's vision changes, the Visian ICL can be removed or exchanged by a trained ophthalmic surgeon. Advantages of the VISIAN ICL™
To learn more about the Visian ICL, schedule an appointment with The Eye Center surgeons. You may also visit Staar Surgical website: www.visianinfo.com |
the time. Eye drops will be given to reduce pupil size. A local and/or IV anesthetic is given so that the procedure is virtually painless. A micro incision is made in the cornea for Verisyse to be placed between the iris and the cornea. The Verisyse IOL is centered in front of the pupil and is gently attached to the iris to hold the lens in place. The small incision is closed with microscopic stitches. A temporary shield may be placed over the eye for protection during the immediate post-op recovery. 
